Replies to post #115767 on Biotech Values

[DewDiligence]

MNTA has a new US Copaxone patent that appears to incorporate MNTA’s workaround to Teva’s “Gad” patents:

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8058235.PN.&OS=PN/8058235&RS=PN/8058235

Thanks to ‘Boing x 2’ for spotting this item.